Breast cancer metastatic and Haemoglobin abnormal

Summary:

Haemoglobin abnormal is found among people with Breast cancer metastatic, especially for people who are female, 60+ old.

The study analyzes which people have Haemoglobin abnormal with Breast cancer metastatic. It is created by eHealthMe based on reports of 146 people who have Breast cancer metastatic from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Breast cancer metastatic?

Breast cancer metastatic is found to be associated with 600 drugs and 471 conditions by eHealthMe. Check the latest studies of Breast cancer metastatic.

What is Haemoglobin abnormal?

Haemoglobin abnormal is found to be associated with 618 drugs and 1,008 conditions by eHealthMe. Check the latest studies of Haemoglobin abnormal.

On Aug, 01, 2026

146 people who have Breast Cancer Metastatic and Haemoglobin Abnormal are studied.

Would you have Haemoglobin abnormal when you have Breast cancer metastatic?

Gender of people who have Breast cancer metastatic and experienced Haemoglobin abnormal *:

Click here to view

Age of people who have Breast cancer metastatic and experienced Haemoglobin abnormal *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Haemoglobin abnormal?

- Check whether Haemoglobin abnormal is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Breast cancer metastatic (91,098 reports)
Haemoglobin abnormal (7,149 reports)

All the drugs that are associated with Haemoglobin abnormal:

Haemoglobin abnormal (618 drugs)

All the conditions that are associated with Haemoglobin abnormal:

Haemoglobin abnormal (1,008 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Haemoglobin abnormal and Breast cancer metastatic, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.